Saturday, July 11, 2026

Drug profile · INN

tirelizumab

tirelizumab is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — tirelizumab
Class
Route
Patents
0
Programs
1
Data quality
0.70

Quick answer

tirelizumab is an FDA-listed pharmaceutical active ingredient.

Key facts

INN tirelizumab

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Anrotinib plus Tirelizumab Phase 2 · Chinese Academy of · Nasopharyngeal Carcinoma

Frequently asked questions

What is tirelizumab?

tirelizumab is an FDA-listed pharmaceutical active ingredient.